The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
What made sesquiterpene lactones reach cancer clinical trials?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Medicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Biological activities of sesquiterpene lactones
., E. R., Towers, G. H. N., & Mitchell, J. C. (1976) · Phytochemistry · doi:10.1016/s0031-9422(00)97430-2 · Cited by 595
Biological activities of sesquiterpene lactones
Picman, A. K. (1986) · Biochemical Systematics and Ecology · doi:10.1016/0305-1978(86)90101-8 · Cited by 538
Kwok, B. H. B., Koh, B., Ndubuisi, M. I., Elofsson, M., & Crews, C. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00049-7 · Cited by 515
Tumor inhibitors. 69. Structure-cytotoxicity relations among the sesquiterpene lactones
Kupchan, S. M., Eakin, M. A., & Thomas, A. M. (1971) · Journal of Medicinal Chemistry · doi:10.1021/jm00294a001 · Cited by 486
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular Mechanisms
Zhang, S., Won, Y.-K., Ong, C.-N., & Shen, H.-M. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011053765976 · Cited by 383
Hehner, S. P., Heinrich, M., Bork, P. M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W., & Schmitz, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1288 · Cited by 338
Bork, P. M., Schmitz, M. L., Kuhnt, M., Escher, C., & Heinrich, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01502-5 · Cited by 327
Reactions of Alpha Methylene Lactone Tumor Inhibitors with Model Biological Nucleophiles
Kupchan, S. M., Fessler, D. C., Eakin, M. A., & Giacobbe, T. J. (1970) · Science · doi:10.1126/science.168.3929.376 · Cited by 298
Efferth, T. (2007) · Planta Medica · doi:10.1055/s-2007-967138 · Cited by 269
Molecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Efferth, T. (2006) · Current Drug Targets · doi:10.2174/138945006776359412 · Cited by 262
The SERCA pump as a therapeutic target: Making a “smart bomb” for prostate cancer
Denmeade, S. R., & Isaacs, J. T. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.1.1505 · Cited by 244
Cytotoxicity of sesquiterpene lactones.
Lee, K., Huang, E., Piantadosi, C. A., Pagano, J. S., & Geissman, T. A. (1971) · PubMed · Cited by 210
Sesquiterpene Antitumor Agents: Inhibitors of Cellular Metabolism
Lee, K.-H., Hall, I. H., Mar, E.-C., Starnes, C. O., ElGebaly, S. A., Waddell, T. G., Hadgraft, R. I., Ruffner, C. G., & Weidner, I. (1977) · Science · doi:10.1126/science.191909 · Cited by 210
Artesunate in the treatment of metastatic uveal melanoma - first experiences
Berger, T., Dieckmann, D., Efferth, T., Schultz, E., Funk, J.-O., Baur, A., & Schuler, G. (2005) · Oncology Reports · doi:10.3892/or.14.6.1599 · Cited by 176
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 169
Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
Liu, Z., Liu, S., Xie, Z., Pavlovicz, R. E., Wu, J., Chen, P., Aimiuwu, J., Pang, J., Bhasin, D. K., Neviani, P., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147934 · Cited by 157
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation
Aldieri, E., Atragene, D., Bergandi, L., Riganti, C., Costamagna, C., Bosìa, A., & Ghigo, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00905-0 · Cited by 153
Antineoplastic Principles in Plants: Recent Developments in the Field
Hartwell, J. L., & Abbott, B. J. (1970) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60561-x · Cited by 141
Schmidt, T. J. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00003-5 · Cited by 141
Nakase, I., Gallis, B. M., Takatani‐Nakase, T., Oh, S. K. W., Lacoste, E., Singh, N. P., Goodlett, D. R., Tanaka, S., Futaki, S., Lai, H. C., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.023 · Cited by 137
Chen, H., Zhou, H., Wu, G.-D., & Lou, X.-E. (2004) · Pharmacology · doi:10.1159/000076256 · Cited by 135
Jordan, C. T. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.10.005 · Cited by 131
Li, W., Dong, Y.-J., Tu, Y., & Lin, Z. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.004 · Cited by 130
Efferth, T., Olbrich, A., & Bauer, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01221-2 · Cited by 129
Anfosso, L., Efferth, T., Albini, A., & Pfeffer, U. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500371 · Cited by 127
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul, H. S. (2007) · Frontiers in bioscience · doi:10.2741/2900 · Cited by 121
Gopal, Y. N. V., Arora, T. S., & Dyke, M. W. V. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.007 · Cited by 120
Structure−Cytotoxicity Relationships of Some Helenanolide-Type Sesquiterpene Lactones
Beekman, A. C., Woerdenbag, H. J., van Uden, W., Pras, N., Konings, A. W. T., Wikström, H., & Schmidt, T. J. (1997) · Journal of Natural Products · doi:10.1021/np960517h · Cited by 120
Quantitative structure–activity relationship of sesquiterpene lactones with cytotoxic activity
Scotti, L., Fernandes, M. B., Ferreira, M. J. P., & Emerenciano, V. P. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.005 · Cited by 118
Zu-yi, Z. (2008) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20080206 · Cited by 118
Idris, A. I., Libouban, H., Nyangoga, H., Landao‐Bassonga, E., Chappard, D., & Ralston, S. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0133 · Cited by 112
Kawasaki, B. T., Hurt, E. M., Kalathur, M., Duhagon, M. A., Milner, J. A., Kim, Y. S., & Farrar, W. L. (2009) · The Prostate · doi:10.1002/pros.20931 · Cited by 102
A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells
Christensen, S. B., Skytte, D. M., Denmeade, S. R., Dionne, C. A., MØLLER, J. V., Nissen, P., & Isaacs, J. T. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520610909030276 · Cited by 97
Cancer stem cells: Models, mechanisms and implications for improved treatment
Zhou, J., & Zhang, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.10.5953 · Cited by 92
Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
Gopal, Y. N. V., Chanchorn, E., & Dyke, M. W. V. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0661 · Cited by 90
Schmidt, T. J., Lyß, G., Pahl, H. L., & Merfort, I. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00234-5 · Cited by 87
Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.
Pająk, B., Gajkowska, B., & Orzechowski, A. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0019-2 · Cited by 83
Case report of a laryngeal squamous cell carcinoma treated with artesunate
Singh, N., & Verma, K. (2002) · Archive of oncology · doi:10.2298/aoo0204279s · Cited by 80
Case Report of a Pituitary Macroadenoma Treated With Artemether
Singh, N. P., & Panwar, V. K. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406295311 · Cited by 77
Lee, K., Furukawa, H., & Huang, E. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00276a010 · Cited by 71
Hall, I. H., Lee, K., Starnes, C. O., Elgebaly, S. A., Ibuka, T., Wu, Y. S., Kimura, T., & Haruna, M. (1978) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600670912 · Cited by 59
Ren, Q., Kari, C., Quadros, M. R. D., Burd, R., McCue, P. A., Dicker, A. P., & Rodeck, U. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4158 · Cited by 56
Fernandes, M. B., Scotti, L., Ferreira, M. J. P., & Emerenciano, V. P. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.003 · Cited by 48
Searching for leukemia stem cells--not yet the end of the road?
Jordan, C. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.010 · Cited by 27
Cited by
Sesquiterpenoids Lactones: Benefits to Plants and People
Chadwick, M., Trewin, H., Gawthrop, F., & Wagstaff, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612780 · Cited by 674
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Parthenolide: from plant shoots to cancer roots
Ghantous, A., Sinjab, A., Herceg, Z., & Darwiche, N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.005 · Cited by 310
Self-citationCell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Self-citationTherapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review
Kamran, S., Sinniah, A., Abdulghani, M. A. M., & Alshawsh, M. A. (2022) · Cancers · doi:10.3390/cancers14051100 · Cited by 259
Metadata
- Authors
- Ghantous, A., Gali-Muhtasib, H., Vuorela, H., Saliba, N. A., & Darwiche, N.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 15
- Issue
- 15-16
- Pages
- 668-678
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2085827306
- Cited by
- 615
- References
- 51
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.